Cancer Clinical Trial -Sidney Kimmel Comprehensive Cancer Center-J2177

Mutant KRAS -Targeted Long Peptide Vaccine for Patients at High Risk of Developing Pancreatic Cancer

Drug

KRAS peptide vaccine

Phase

Phase I

Condition

Pancreatic

Keywords

KRAS